world
Breakthrough Cancer Treatment Shows 90% Remission Rate in Phase III Clinical Trials
A novel immunotherapy approach demonstrates a 90% remission rate across three major cancer types in the largest Phase III trial of its kind.
David Park | Apr 12, 2026